OpenURL Connection Search

Select item for more details and to access through your institution.

Autologous stem cell transplantation for untreated transformed indolent B‐cell lymphoma in first remission: an international, multi‐centre propensity‐score‐matched study.
Published in:
British Journal of Haematology, 2020, v. 191, n. 5, p. 806, doi. 10.1111/bjh.17072
By:
- Chin, C. K.;
- Lim, K. J.;
- Lewis, K.;
- Jain, P.;
- Qing, Y.;
- Feng, L.;
- Cheah, C. Y.;
- Seymour, J. F.;
- Ritchie, D.;
- Burbury, K.;
- Tam, C. S.;
- Fowler, N. H.;
- Fayad, L. E.;
- Westin, J. R.;
- Neelapu, S. S.;
- Hagemeister, F. B.;
- Samaniego, F.;
- Flowers, C. R.;
- Nastoupil, L. J.;
- Dickinson, M. J.
Publication type:
Article
ZUMA‐22: A PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL (AXI‐CEL) VS STANDARD‐OF‐CARE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA.
Published in:
Hematological Oncology, 2023, v. 41, p. 853, doi. 10.1002/hon.3166_OT31
By:
- Flinn, I. W.;
- Jacobson, C. A.;
- Nastoupil, L. J.;
- Morschhauser, F.;
- Davies, A.;
- Buske, C.;
- Corradini, P.;
- Lopez‐Guillermo, A.;
- Reshef, R.;
- Parameswaran, V.;
- Sehgal, A.;
- Tees, M.;
- Lui, C.;
- Xue, W.;
- Beygi, S.;
- Grechko, N.;
- Bolsue, P.;
- Giovanetti, A.;
- To, C.;
- Nahas, M.
Publication type:
Article
SMART STOP: A PHASE II CLINICAL TRIAL OF LENALIDOMIDE, TAFASITAMAB, RITUXIMAB, AND ACALABRUTINIB ALONE AND WITH RESPONSE ADAPTED CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED DLBCL.
Published in:
Hematological Oncology, 2023, v. 41, p. 837, doi. 10.1002/hon.3166_OT17
By:
- Westin, J.;
- Strati, P.;
- Chihara, D.;
- Pulsifer, B.;
- Tom, J.;
- Davis, R. E.;
- Lee, H. J.;
- Nair, R.;
- Rodriguez, A.;
- Hagemeister, F.;
- Flowers, C.;
- Nastoupil, L.;
- Feng, L.;
- Green, M.;
- Fayad, L.;
- Iyer, S.;
- Ahmed, S.;
- Steiner, R.
Publication type:
Article
Brentuximab Vedotin‐Nivolumab alone and then with Rituximab‐Cyclophosphamide‐Doxorubicin‐Prednisone as Frontline Therapy of Primary Mediastinal Large B‐cell Lymphoma.
Published in:
Hematological Oncology, 2023, v. 41, p. 167, doi. 10.1002/hon.3163_T03
By:
- Steiner, R. E.;
- Strati, P.;
- Flowers, C. R.;
- Neelapu, S. S.;
- Green, M.;
- Nastoupil, L. J.;
- Hagemeister, F. B.;
- Feng, L.;
- Ahmed, S.;
- Nair, R.;
- Fayad, L.;
- Lee, H. J.;
- Rodriguez, M. A.;
- Westin, J. R.
Publication type:
Article
MAHOGANY: A PHASE 3 TRIAL OF ZANUBRUTINIB PLUS ANTI‐CD20 VERSUS LENALIDOMIDE PLUS RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR OR MARGINAL ZONE LYMPHOMA.
Published in:
Hematological Oncology, 2023, v. 41, p. 168, doi. 10.1002/hon.3163_T04
By:
- Sehn, L.;
- Sarkozy, C.;
- Song, Y.;
- Salar, A.;
- Trotman, J.;
- Zinzani, P. L.;
- Zhang, J.;
- Zhang, W.;
- Fustier, P.;
- Delarue, R.;
- Nastoupil, L.
Publication type:
Article
IBRUTINIB PLUS BR OR R‐CHOP IN PREVIOUSLY TREATED PATIENTS WITH FOLLICULAR OR MARGINAL ZONE LYMPHOMA: THE PHASE 3 SELENE STUDY.
Published in:
Hematological Oncology, 2023, v. 41, p. 872, doi. 10.1002/hon.3196_LBA2
By:
- Nastoupil, L. J.;
- Hess, G.;
- Pavlovsky, M. A.;
- Danielewicz, I.;
- Freeman, J.;
- García‐Sancho, A. M.;
- Glazunova, V.;
- Grigg, A.;
- Hou, J.;
- Janssens, A.;
- Kim, S. J.;
- Masliak, Z.;
- McKay, P.;
- Merli, F.;
- Munakata, W.;
- Nagai, H.;
- Özcan, M.;
- Preis, M.;
- Wang, T.;
- Zhu, J.
Publication type:
Article
ACALABRUTINIB WITH RITUXIMAB AS FIRST‐LINE THERAPY FOR OLDER PATIENTS WITH MANTLE CELL LYMPHOMA—A PHASE II CLINICAL TRIAL.
Published in:
Hematological Oncology, 2023, v. 41, p. 150, doi. 10.1002/hon.3163_99
By:
- Jain, P.;
- Ok, C. y.;
- Fetooh, A.;
- Nastoupil, L.;
- Westin, J.;
- Hill, H. A.;
- Nair, R.;
- Iyer, S. P.;
- Steiner, R. E.;
- Lee, H. J.;
- Ahmed, S.;
- Kanagal‐Shamanna, R.;
- Jelloul, F. Z.;
- Castillo, L. E. Malpica;
- Liu, Y.;
- Vargas, J.;
- Feng, L.;
- Badillo, M.;
- Thirumurthi, S.;
- Xu, G.
Publication type:
Article
OPEN‐LABEL PHASE 1/2 STUDY OF CC‐99282, A CEREBLON E3 LIGASE MODULATOR (CELMOD) AGENT ± RITUXIMAB, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) NON‐HODGKIN LYMPHOMA (NHL).
Published in:
Hematological Oncology, 2023, v. 41, p. 134, doi. 10.1002/hon.3163_90
By:
- Michot, J. M.;
- Chavez, J.;
- Carpio, C.;
- Bachy, E.;
- Ferrari, S.;
- Morschhauser, F.;
- Jørgensen, J. M.;
- Cordoba, R.;
- Bories, P.;
- Patah, P.;
- de Moucheron, B.;
- Carrancio, S.;
- Guarinos, C.;
- Zheng, X.;
- Mei, C.;
- Pourdehnad, M.;
- Nastoupil, L.
Publication type:
Article
MOSUNETUZUMAB DEMONSTRATES DURABLE RESPONSES IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AND ≥2 PRIOR THERAPIES: UPDATED ANALYSIS OF A PIVOTAL PHASE II STUDY.
Published in:
Hematological Oncology, 2023, v. 41, p. 122, doi. 10.1002/hon.3163_83
By:
- Sehn, L. H.;
- Bartlett, N. L.;
- Matasar, M.;
- Schuster, S. J.;
- Assouline, S.;
- Giri, P.;
- Kuruvilla, J.;
- Shadman, M.;
- Cheah, C. Y.;
- Fay, K.;
- Ku, M.;
- Nastoupil, L.;
- Wei, M. C.;
- Yin, S.;
- To, I.;
- Hu, N.;
- Min, J.;
- Penuel, E.;
- Belousov, A.;
- Coimbra, A.
Publication type:
Article
RADIOMICS REFLECTING BOTH TUMOR AND HOST FEATURES IMPROVES OUTCOME PREDICTION IN FOLLICULAR LYMPHOMA.
Published in:
Hematological Oncology, 2023, v. 41, p. 94, doi. 10.1002/hon.3163_58
By:
- Rebaud, L.;
- Capobianco, N.;
- Spottiswoode, B.;
- Cottereau, A.;
- Trotman, J.;
- Feugier, P.;
- Nastoupil, L. J.;
- Bachy, E.;
- Flinn, I. W.;
- Haioun, C.;
- Ysebaert, L.;
- Bartlett, N. L.;
- Tilly, H.;
- Casasnovas, R.;
- Ricci, R.;
- Portugues, C.;
- Meignan, M.;
- Morschhauser, F.;
- Buvat, I.
Publication type:
Article
Defining Primary Refractory Diffuse Large B‐cell Lymphoma (DLBCL) Based on Survival Outcomes.
Published in:
Hematological Oncology, 2023, v. 41, p. 430, doi. 10.1002/hon.3164_317
By:
- Bock, A. M.;
- Mwangi, R.;
- Wang, Y.;
- Khurana, A.;
- Maurer, M. J.;
- Ayers, A.;
- Kahl, B.;
- Martin, P.;
- Cohen, J.;
- Casulo, C.;
- Lossos, I.;
- Farooq, U.;
- Ayyappan, S.;
- Reicks, T.;
- Habermann, T. M.;
- Flowers, C. R.;
- Cerhan, J. R.;
- Nastoupil, L. J.;
- Nowakowski, G. S.
Publication type:
Article
A Phase II Investigator Initiated Study of Acalabrutinib, Lenalidomide and Rituximab (aR2) in Patients with Previously Untreated High Tumor Burden Follicular Lymphoma.
Published in:
Hematological Oncology, 2023, v. 41, p. 383, doi. 10.1002/hon.3164_277
By:
- Strati, P.;
- Feng, L.;
- Westin, J.;
- Nair, R.;
- Gouni, S.;
- Fayad, L.;
- Rodriguez, M.;
- Chihara, D.;
- Malpica, L.;
- Steiner, R.;
- Gallardo, M.;
- Nastoupil, L.;
- Neelapu, S.
Publication type:
Article
A low lymphocyte‐to‐monocyte ratio (LMR) predicts PFS, POD24 and OS in previously untreated, high tumor burden follicular lymphoma (FL): an analysis from the RELEVANCE trial.
Published in:
Hematological Oncology, 2023, v. 41, p. 290, doi. 10.1002/hon.3164_200
By:
- Mozas, P.;
- Ammar, R. Ould;
- Chartier, L.;
- Nastoupil, L.;
- Bachy, E.;
- Bezsera, S. M.;
- Barnes, J.;
- Bijou, F.;
- Goy, A.;
- Zerazhi, H.;
- Cartron, G.;
- Ojeda‐Uribe, M.;
- Choquet, S.;
- Joly, B.;
- Cheminant, M.;
- García‐Sancho, A. Martín;
- Eradat, H.;
- Gressin, R.;
- Abrisqueta, P.;
- Parcelier, A.
Publication type:
Article
LISOCABTAGENE MARALEUCEL (LISO‐CEL) VERSUS STANDARD OF CARE (SOC) AS SECOND‐LINE THERAPY IN LARGE B‐CELL LYMPHOMA (TRANSFORM STUDY): SUBGROUP ANALYSES BY PRIOR THERAPY RESPONSE.
Published in:
Hematological Oncology, 2023, v. 41, p. 212, doi. 10.1002/hon.3163_138
By:
- Nastoupil, L. J.;
- Kamdar, M.;
- Chavez, J. C.;
- Ghesquieres, H.;
- Ghosh, M.;
- Holmes, H.;
- López‐Guillermo, A.;
- Martínez‐López, J.;
- Novak, U.;
- Ribrag, V.;
- Roddie, C.;
- Waller, E. K.;
- Feldman, T.;
- Rosenthal, A. C.;
- Sauter, C.;
- von Bonin, M.;
- Karmali, R.;
- Montheard, S.;
- Previtali, A.;
- Abramson, J.
Publication type:
Article
IBRUTINIB‐RITUXIMAB AND VENETOCLAX (IRV) FOLLOWED BY RISK‐STRATIFIED R‐HYPERCVAD/MTX IN YOUNG PATIENTS WITH UNTREATED MANTLE CELL LYMPHOMA—PHASE‐II WINDOW‐2 TRIAL.
Published in:
Hematological Oncology, 2023, v. 41, p. 152, doi. 10.1002/hon.3163_101
By:
- Wang, M. L.;
- Lee, H. J.;
- Fetooh, A.;
- Nair, R.;
- Ok, C. Y.;
- Hill, H. A.;
- Iyer, S. P;
- Steiner, R. E.;
- Westin, J.;
- Nastoupil, L.;
- Fowler, N.;
- Kanagal‐Shamanna, R.;
- Jelloul, F. Z.;
- Castillo, L. E. Malpica;
- Liu, Y.;
- Li, Y.;
- Vargas, J.;
- Feng, L.;
- Badillo, M.;
- Spike, T.
Publication type:
Article
A PHASE 1, MULTICENTER, OPEN‐LABEL STUDY OF CC‐99282 ALONE AND IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY NON‐HODGKIN LYMPHOMAS.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.89_2881
By:
- Michot, J.‐M.;
- Carpio, C.;
- Nastoupil, L.;
- Chavez, J.;
- Feldman, T.;
- Ferrari, S.;
- Morillo, D.;
- Bachy, E.;
- Pinto, A.;
- Kuruvilla, J.;
- Buchholz, T. J.;
- Kasibhatla, S.;
- Carrancio, S.;
- Guarinos, C.;
- Wu, F.;
- Li, S.;
- Patah, P.;
- Pourdehnad, M.
Publication type:
Article
CARDIOVASCULAR EVENTS AMONG ADULT PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA TREATED WITH STANDARD OF CARE AXICABTAGENE CILOLEUCEL AND TISAGENLECLEUCEL.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.177_2880
By:
- Steiner, R.;
- Banchs, J.;
- Koutroumpakis, E.;
- Becnel, M.;
- Gutierrez, C.;
- Strati, P.;
- Pinnix, C.;
- Feng, L.;
- Claussen, C.;
- Palaskas, N.;
- Karimzad, K.;
- Ahmed, S.;
- Neelapu, S.;
- Shpall, E.;
- Wang, M.;
- Vega, F.;
- Westin, J.;
- Nastoupil, L.;
- Deswal, A.
Publication type:
Article
VERY EARLY FDG PET/CT SCAN MAY PREDICT OUTCOMES IN RELAPSED OR REFRACTORY DLBCL PATIENTS TREATED WITH SALVAGE THERAPY.
Published in:
Hematological Oncology, 2019, v. 37, p. 410, doi. 10.1002/hon.79_2631
By:
- Westin, J.R.;
- Nastoupil, L.;
- Fayad, L.;
- Hagemeister, F.;
- Young, K.;
- McDonnell, T.;
- Neelapu, S.;
- Davis, R.E.;
- Green, M.;
- Ahmed, S.;
- Nair, R.;
- Steiner, R.;
- Lee, H.;
- Rodriguez, M.;
- Parmar, S.;
- Chuang, H.
Publication type:
Article
COMPREHENSIVE ANALYSIS OF PROGNOSTIC FACTORS, OUTCOMES AND MUTATION PROFILE IN PATIENTS WITH AGGRESSIVE HISTOLOGY (BLASTOID/PLEOMORPHIC) OR TRANSFORMED MANTLE CELL LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 238, doi. 10.1002/hon.49_2630
By:
- Jain, P.;
- Kanagal‐Shamanna, R.;
- Zhang, S.;
- Ok, C.;
- Nogueras Gonzalez, G.;
- Gonzalez‐Pagan, O.;
- Ghorab, A.;
- Boddu, P.;
- Chen, W.;
- Lee, H. Ju;
- Nomie, K.;
- Fayad, L.;
- Westin, J.;
- Nastoupil, L.;
- Patel, K.;
- Ahmed, S.;
- Iyer, S.P.;
- Parmar, S.;
- Champlin, R.;
- Neelapu, S.
Publication type:
Article
SMART START: RITUXIMAB, LENALIDOMIDE, AND IBRUTINIB ALONE PRIOR TO COMBINATION WITH CHEMOTHERAPY FOR PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 78, doi. 10.1002/hon.48_2629
By:
- Westin, J.R.;
- Nastoupil, L.;
- Hagemeister, F.;
- Fayad, L.;
- Young, K.;
- McDonnell, T.;
- Chuang, H.;
- Ahmed, S.;
- Nair, R.;
- Steiner, R.;
- Lee, H.;
- Rodriguez, M.;
- Parmar, S.;
- Green, M.;
- Neelapu, S.;
- Davis, R.
Publication type:
Article
PROGNOSTIC VALUE OF PRE‐TREATMENT PET SCAN IN PATIENTS WITH FOLLICULAR LYMPHOMA RECEIVING FRONTLINE THERAPY.
Published in:
Hematological Oncology, 2019, v. 37, p. 53, doi. 10.1002/hon.22_2629
By:
- Strati, P.;
- Ahmed, M.;
- Fowler, N.;
- Hagemeister, F.;
- Fayad, L.;
- Rodriguez, M.;
- Samaniego, F.;
- Wang, M.;
- Westin, J.R.;
- Romaguera, J.;
- Noorani, M.;
- Phansalkar, K.;
- Cheah, C.;
- Feng, L.;
- Davis, R.E.;
- Nastoupil, L.;
- Neelapu, S.S.
Publication type:
Article
AN ONGOING PHASE 1/1B TRIAL INVESTIGATING NOVEL TREATMENT REGIMENS WITH MOSUNETUZUMAB IN RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 567, doi. 10.1002/hon.15_2632
By:
- Kim, W.S.;
- Assouline, S.;
- Bartlett, N.L.;
- Bosch, F.;
- Budde, L.E.;
- Cheah, C.;
- Gregory, G.P.;
- Hong, J.;
- Ku, M.;
- Marlton, P.;
- Matasar, M.;
- Nastoupil, L.;
- Panizo, C.;
- Sehn, L.H.;
- Tzachanis, D.;
- Chu, W.;
- Hernandez, M.G.;
- Kwan, A.;
- Li, C.C.;
- Sison, I.
Publication type:
Article
DIFFUSE LARGE B CELL LYMPHOMA WITH SECONDARY CENTRAL NERVOUS SYSTEM INVOLVEMENT: CAN MRI PATTERN HELP PREDICTING OUTCOME?
Published in:
Hematological Oncology, 2019, v. 37, p. 442, doi. 10.1002/hon.118_2631
By:
- Dabaja, B.;
- Gule‐Monroe, M.;
- Gunther, J.R.;
- Milgrom, S.;
- Sheu, T.;
- Nair, R.;
- Ahmed, S.;
- Steiner, R.;
- Strati, P.;
- Nastoupil, L.;
- Neelapu, S.;
- Pinnix, C.;
- Fowler, N.
Publication type:
Article
CLINICAL IMPLICATIONS OF CYTOPENIAS BEYOND DAY 30 AFTER AXI‐CEL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 311, doi. 10.1002/hon.120_2630
By:
- Strati, P.;
- Adkins, S.;
- Nastoupil, L.;
- Westin, J.;
- Hagemeister, F.;
- Fowler, N.;
- Lee, H.J.;
- Fayad, L.;
- Samaniego, F.;
- Ahmed, S.;
- Varma, A.;
- Arafat, S.;
- Johncy, S.;
- Kebriaei, P.;
- Mulanovich, V.E.;
- Ariza Heredia, E.;
- Neelapu, S.S.
Publication type:
Article
IBRUTINIB WITH RITUXIMAB (IR) AND SHORT COURSE R‐HYPERCVAD/MTX IS VERY EFFICACIOUS IN PREVIOUSLY UNTREATED YOUNG PTS WITH MANTLE CELL LYMPHOMA (MCL).
Published in:
Hematological Oncology, 2019, v. 37, p. 42, doi. 10.1002/hon.12_2629
By:
- Wang, M.;
- Jain, P.;
- Zhang, S.;
- Nomie, K.;
- Wang, L.;
- Oriabure, O.;
- Nogueras Gonzales, G.;
- Zhang, L.;
- Wagner‐Bartak, N.;
- Hagemeister, F.;
- Samaniego, F.;
- Westin, J.;
- Lee, H.J.;
- Nastoupil, L.;
- Ok, C.;
- Kanagal‐Shamanna, R.;
- Chen, W.;
- Thirumurthi, S.;
- Santos, D.;
- Badillo, M.
Publication type:
Article
MANAGING CYTOKINE RELEASE SYNDROME (CRS) AND NEUROTOXICITY WITH STEP‐UP DOSING OF MOSUNETUZUMAB IN RELAPSED/REFRACTORY (R/R) B‐CELL NON‐HODGKIN LYMPHOMA (NHL).
Published in:
Hematological Oncology, 2019, v. 37, p. 310, doi. 10.1002/hon.119_2630
By:
- Sehn, L.H.;
- Assouline, S.;
- Bartlett, N.L.;
- Bosch, F.;
- Diefenbach, C.M.;
- Flinn, I.;
- Hong, J.Y.;
- Kim, W.S.;
- Matasar, M.;
- Nastoupil, L.;
- Schuster, S.J.;
- Shadman, M.;
- Yoon, S.S.;
- Bender, B.;
- Chu, W.;
- Hernandez, G.M.;
- Kwan, A.;
- McCall, B.;
- Sison, I.;
- Wang, C.
Publication type:
Article
COMBINATION OF IBRUTINIB WITH RITUXIMAB (IR) IS HIGHLY EFFECTIVE IN PREVIOUSLY UNTREATED ELDERLY (>65 YEARS) PATIENTS (PTS) WITH MANTLE CELL LYMPHOMA (MCL) – PHASE II TRIAL.
Published in:
Hematological Oncology, 2019, v. 37, p. 42, doi. 10.1002/hon.11_2629
By:
- Jain, P.;
- Romaguera, J.;
- Nomie, K.;
- Zhang, S.;
- Wang, L.;
- Oriabure, O.;
- Wagner‐Bartak, N.;
- Zhang, L.;
- Hagemeister, F.;
- Samaniego, F.;
- Westin, J.;
- Ju Lee, H.;
- Nastoupil, L.;
- Iyer, S.;
- Parmar, S.;
- Ok, C.;
- Kanagal‐Shamanna, R.;
- Chen, W.;
- Thirumurthi, S.;
- Santos, D.
Publication type:
Article
VERY EARLY FDG PET/CT SCAN MAY PREDICT OUTCOMES IN RELAPSED OR REFRACTORY DLBCL PATIENTS TREATED WITH SALVAGE THERAPY.
Published in:
Hematological Oncology, 2019, v. 37, p. 410, doi. 10.1002/hon.79_2631
By:
- Westin, J.R.;
- Nastoupil, L.;
- Fayad, L.;
- Hagemeister, F.;
- Young, K.;
- McDonnell, T.;
- Neelapu, S.;
- Davis, R.E.;
- Green, M.;
- Ahmed, S.;
- Nair, R.;
- Steiner, R.;
- Lee, H.;
- Rodriguez, M.;
- Parmar, S.;
- Chuang, H.
Publication type:
Article
COMPREHENSIVE ANALYSIS OF PROGNOSTIC FACTORS, OUTCOMES AND MUTATION PROFILE IN PATIENTS WITH AGGRESSIVE HISTOLOGY (BLASTOID/PLEOMORPHIC) OR TRANSFORMED MANTLE CELL LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 238, doi. 10.1002/hon.49_2630
By:
- Jain, P.;
- Kanagal‐Shamanna, R.;
- Zhang, S.;
- Ok, C.;
- Nogueras Gonzalez, G.;
- Gonzalez‐Pagan, O.;
- Ghorab, A.;
- Boddu, P.;
- Chen, W.;
- Lee, H. Ju;
- Nomie, K.;
- Fayad, L.;
- Westin, J.;
- Nastoupil, L.;
- Patel, K.;
- Ahmed, S.;
- Iyer, S.P.;
- Parmar, S.;
- Champlin, R.;
- Neelapu, S.
Publication type:
Article
SMART START: RITUXIMAB, LENALIDOMIDE, AND IBRUTINIB ALONE PRIOR TO COMBINATION WITH CHEMOTHERAPY FOR PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 78, doi. 10.1002/hon.48_2629
By:
- Westin, J.R.;
- Nastoupil, L.;
- Hagemeister, F.;
- Fayad, L.;
- Young, K.;
- McDonnell, T.;
- Chuang, H.;
- Ahmed, S.;
- Nair, R.;
- Steiner, R.;
- Lee, H.;
- Rodriguez, M.;
- Parmar, S.;
- Green, M.;
- Neelapu, S.;
- Davis, R.
Publication type:
Article
PROGNOSTIC VALUE OF PRE‐TREATMENT PET SCAN IN PATIENTS WITH FOLLICULAR LYMPHOMA RECEIVING FRONTLINE THERAPY.
Published in:
Hematological Oncology, 2019, v. 37, p. 53, doi. 10.1002/hon.22_2629
By:
- Strati, P.;
- Ahmed, M.;
- Fowler, N.;
- Hagemeister, F.;
- Fayad, L.;
- Rodriguez, M.;
- Samaniego, F.;
- Wang, M.;
- Westin, J.R.;
- Romaguera, J.;
- Noorani, M.;
- Phansalkar, K.;
- Cheah, C.;
- Feng, L.;
- Davis, R.E.;
- Nastoupil, L.;
- Neelapu, S.S.
Publication type:
Article
AN ONGOING PHASE 1/1B TRIAL INVESTIGATING NOVEL TREATMENT REGIMENS WITH MOSUNETUZUMAB IN RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 567, doi. 10.1002/hon.15_2632
By:
- Kim, W.S.;
- Assouline, S.;
- Bartlett, N.L.;
- Bosch, F.;
- Budde, L.E.;
- Cheah, C.;
- Gregory, G.P.;
- Hong, J.;
- Ku, M.;
- Marlton, P.;
- Matasar, M.;
- Nastoupil, L.;
- Panizo, C.;
- Sehn, L.H.;
- Tzachanis, D.;
- Chu, W.;
- Hernandez, M.G.;
- Kwan, A.;
- Li, C.C.;
- Sison, I.
Publication type:
Article
CLINICAL IMPLICATIONS OF CYTOPENIAS BEYOND DAY 30 AFTER AXI‐CEL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 311, doi. 10.1002/hon.120_2630
By:
- Strati, P.;
- Adkins, S.;
- Nastoupil, L.;
- Westin, J.;
- Hagemeister, F.;
- Fowler, N.;
- Lee, H.J.;
- Fayad, L.;
- Samaniego, F.;
- Ahmed, S.;
- Varma, A.;
- Arafat, S.;
- Johncy, S.;
- Kebriaei, P.;
- Mulanovich, V.E.;
- Ariza Heredia, E.;
- Neelapu, S.S.
Publication type:
Article
IBRUTINIB WITH RITUXIMAB (IR) AND SHORT COURSE R‐HYPERCVAD/MTX IS VERY EFFICACIOUS IN PREVIOUSLY UNTREATED YOUNG PTS WITH MANTLE CELL LYMPHOMA (MCL).
Published in:
Hematological Oncology, 2019, v. 37, p. 42, doi. 10.1002/hon.12_2629
By:
- Wang, M.;
- Jain, P.;
- Zhang, S.;
- Nomie, K.;
- Wang, L.;
- Oriabure, O.;
- Nogueras Gonzales, G.;
- Zhang, L.;
- Wagner‐Bartak, N.;
- Hagemeister, F.;
- Samaniego, F.;
- Westin, J.;
- Lee, H.J.;
- Nastoupil, L.;
- Ok, C.;
- Kanagal‐Shamanna, R.;
- Chen, W.;
- Thirumurthi, S.;
- Santos, D.;
- Badillo, M.
Publication type:
Article
MANAGING CYTOKINE RELEASE SYNDROME (CRS) AND NEUROTOXICITY WITH STEP‐UP DOSING OF MOSUNETUZUMAB IN RELAPSED/REFRACTORY (R/R) B‐CELL NON‐HODGKIN LYMPHOMA (NHL).
Published in:
Hematological Oncology, 2019, v. 37, p. 310, doi. 10.1002/hon.119_2630
By:
- Sehn, L.H.;
- Assouline, S.;
- Bartlett, N.L.;
- Bosch, F.;
- Diefenbach, C.M.;
- Flinn, I.;
- Hong, J.Y.;
- Kim, W.S.;
- Matasar, M.;
- Nastoupil, L.;
- Schuster, S.J.;
- Shadman, M.;
- Yoon, S.S.;
- Bender, B.;
- Chu, W.;
- Hernandez, G.M.;
- Kwan, A.;
- McCall, B.;
- Sison, I.;
- Wang, C.
Publication type:
Article
DIFFUSE LARGE B CELL LYMPHOMA WITH SECONDARY CENTRAL NERVOUS SYSTEM INVOLVEMENT: CAN MRI PATTERN HELP PREDICTING OUTCOME?
Published in:
Hematological Oncology, 2019, v. 37, p. 442, doi. 10.1002/hon.118_2631
By:
- Dabaja, B.;
- Gule‐Monroe, M.;
- Gunther, J.R.;
- Milgrom, S.;
- Sheu, T.;
- Nair, R.;
- Ahmed, S.;
- Steiner, R.;
- Strati, P.;
- Nastoupil, L.;
- Neelapu, S.;
- Pinnix, C.;
- Fowler, N.
Publication type:
Article
COMBINATION OF IBRUTINIB WITH RITUXIMAB (IR) IS HIGHLY EFFECTIVE IN PREVIOUSLY UNTREATED ELDERLY (>65 YEARS) PATIENTS (PTS) WITH MANTLE CELL LYMPHOMA (MCL) – PHASE II TRIAL.
Published in:
Hematological Oncology, 2019, v. 37, p. 42, doi. 10.1002/hon.11_2629
By:
- Jain, P.;
- Romaguera, J.;
- Nomie, K.;
- Zhang, S.;
- Wang, L.;
- Oriabure, O.;
- Wagner‐Bartak, N.;
- Zhang, L.;
- Hagemeister, F.;
- Samaniego, F.;
- Westin, J.;
- Ju Lee, H.;
- Nastoupil, L.;
- Iyer, S.;
- Parmar, S.;
- Ok, C.;
- Kanagal‐Shamanna, R.;
- Chen, W.;
- Thirumurthi, S.;
- Santos, D.
Publication type:
Article
VENETOCLAX (VEN), BENDAMUSTINE (B) AND RITUXIMAB (R) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) NON-HODGKIN LYMPHOMA (NHL): FINAL RESULTS OF a PHASE I STUDY.
Published in:
Hematological Oncology, 2017, v. 35, p. 90, doi. 10.1002/hon.2437_78
By:
- Swinnen, L.J.;
- Flowers, C.R.;
- Wang, D.;
- Reid, E.;
- Fowler, N.;
- Cordero, J.;
- Dunbar, M.;
- Enschede, S.;
- Nolan, C.;
- Petrich, A.M.;
- Ross, J.;
- Salem, A.H.;
- Verdugo, M.;
- Wong, S.;
- Zhou, L.;
- Kozloff, M.;
- Nastoupil, L.;
- Vos, S.
Publication type:
Article
LENALIDOMIDE AND OBINUTUZUMAB WITH CHOP FOR NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA: PHASE I/II RESULTS.
Published in:
Hematological Oncology, 2017, v. 35, p. 267, doi. 10.1002/hon.2438_138
By:
- Westin, J.R.;
- Oki, Y.;
- Nastoupil, L.;
- Fayad, L.;
- Neelapu, S.;
- Turturro, F.;
- Hagemeister, F.B.;
- Rodriguez, A.;
- Lee, H.J.;
- Young, K.H.;
- McDonnell, T.;
- Ford, R.;
- Davis, R.E.
Publication type:
Article
CHEMO-FREE TRIPLET COMBINATION OF TGR-1202, UBLITUXIMAB, AND IBRUTINIB IS WELL TOLERATED AND HIGHLY ACTIVE IN PATIENTS WITH ADVANCED CLL AND NHL.
Published in:
Hematological Oncology, 2017, v. 35, p. 112, doi. 10.1002/hon.2437_101
By:
- Nastoupil, L.;
- Lunning, M.A.;
- Vose, J.M.;
- Schreeder, M.T.;
- Siddiqi, T.;
- Flowers, C.R.;
- Cohen, J.B.;
- Burger, J.A.;
- Wierda, W.G.;
- O'Brien, S.;
- Sportelli, P.;
- Miskin, H.P.;
- Purdom, M.A.;
- Weiss, M.S.;
- Fowler, N.H.
Publication type:
Article
RITUXIMAB, LENALIDOMIDE, AND IBRUTINIB ALONE AND COMBINED WITH CHEMOTHERAPY FOR PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA.
Published in:
Hematological Oncology, 2017, v. 35, p. 190, doi. 10.1002/hon.2438_51
By:
- Westin, J.R.;
- Fayad, L.;
- Oki, Y.;
- Nastoupil, L.;
- Hagemeister, F.;
- Turturro, F.;
- Lee, H.J.;
- Rodriguez, A.;
- Young, K.H.;
- McDonnell, T.;
- Ford, R.;
- Neelapu, S.;
- Davis, R.E.
Publication type:
Article
THE IMMUNOLOGIC DOUBLET OF LENALIDOMIDE PLUS OBINUTUZUMAB IS HIGHLY ACTIVE IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA, RESULTS OF A PHASE I/II STUDY.
Published in:
Hematological Oncology, 2017, v. 35, p. 268, doi. 10.1002/hon.2438_140
By:
- Fowler, N.H.;
- Samaniego, F.;
- Turturro, F.;
- Neelapu, S.;
- Forbes, S.;
- Westin, J.;
- Fayad, L.;
- Fanale, M.;
- Feng, L.;
- Arafat, J.;
- Neal, E.;
- Hagemeister, F.;
- Nastoupil, L.
Publication type:
Article
TREATMENT WITH COMBINATION OF LENALIDOMIDE AND RITUXIMAB ACHIEVES DURABLE RESPONSES IN A LONG TERM FOLLOW UP OF PATIENTS WITH INDOLENT NON-HODGKIN'S LYMPHOMA.
Published in:
Hematological Oncology, 2017, v. 35, p. 215, doi. 10.1002/hon.2438_79
By:
- Chaudhry, M.;
- Nastoupil, L.;
- Samaniego, F.;
- Neelapu, S.S.;
- Hagemeister, F.B.;
- Fanale, M.A.;
- Fayad, L.;
- Westin, J.R.;
- Oki, Y.;
- Feng, L.;
- Fowler, N.
Publication type:
Article

Found: 43